ArticleFrontiers in cardiovascular medicine2024

Proprotein convertase subtilisin/kexin type 9 inhibitors protect against contrast-associated acute kidney injury in patients with atherosclerotic cardiovascular disease.

Yu Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.